SCHEMBL24251666

SCHEMBL24251666

CCOC(=O)C(C(=O)OC(C)(C)C)c1nc(OC)ccc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 17/20 0.44
ALDH1A1 P00352 1/20 0.44
GSR P00390 1/20 0.42
GSTP1 P09211 1/20 0.38
GSTM2 P28161 1/20 0.38
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29392101 1.00 TXNRD1 (0.44) TXNRD1ALDH1A1GSRGSTP1GSTM2
SCHEMBL9524102 0.92 TXNRD1 (0.51) TXNRD1ALDH1A1GSRMAPTMAPK1
SCHEMBL24496404 0.87 ALDH1A1 (0.43) ALDH1A1GSTP1GSTM2LMNAMAPT
SCHEMBL3961361 0.85 KMT2A (0.44) TXNRD1ALDH1A1GSRGSTP1GSTM2
SCHEMBL30937582 0.83 ALDH1A1 (0.60) TXNRD1ALDH1A1GSRMAPTMAPK1
SCHEMBL14333655 0.81 ALDH1A1 (0.46) TXNRD1ALDH1A1GSRGSTP1GSTM2
SCHEMBL20066169 0.80 TXNRD1 (0.49) TXNRD1ALDH1A1GSRMAPTMAPK1
SCHEMBL31292368 0.80 LMNA (0.41) TXNRD1ALDH1A1GSTP1GSTM2LMNA
SCHEMBL31347036 0.80 ALDH1A1 (0.67) ALDH1A1LMNAMAPTMAPK1KMT2A
SCHEMBL24496548 0.80 ALDH1A1 (0.67) ALDH1A1LMNAMAPTMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115836064-A Triazine derivative with EGFR (epidermal growth factor receptor) inhibitory activity and preparation method and application thereof 上海和誉生物医药科技有限公司 2023-03-21 CN disclosed
WO-2022033455-A1 TRIAZINE DERIVATIVE HAVING EGFR INHIBITORY ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF 上海和誉生物医药科技有限公司 2022-02-17 WO disclosed